370 related articles for article (PubMed ID: 19858202)
1. Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling.
Börner C; Smida M; Höllt V; Schraven B; Kraus J
J Biol Chem; 2009 Dec; 284(51):35450-60. PubMed ID: 19858202
[TBL] [Abstract][Full Text] [Related]
2. Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor.
Vang T; Torgersen KM; Sundvold V; Saxena M; Levy FO; Skålhegg BS; Hansson V; Mustelin T; Taskén K
J Exp Med; 2001 Feb; 193(4):497-507. PubMed ID: 11181701
[TBL] [Abstract][Full Text] [Related]
3. Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction.
Sánchez MG; Ruiz-Llorente L; Sánchez AM; Díaz-Laviada I
Cell Signal; 2003 Sep; 15(9):851-9. PubMed ID: 12834810
[TBL] [Abstract][Full Text] [Related]
4. Expression and functions of μ-opioid receptors and cannabinoid receptors type 1 in T lymphocytes.
Kraus J
Ann N Y Acad Sci; 2012 Jul; 1261():1-6. PubMed ID: 22823387
[TBL] [Abstract][Full Text] [Related]
5. Involvement of ERK1/2, cPLA2 and NF-κB in microglia suppression by cannabinoid receptor agonists and antagonists.
Ribeiro R; Wen J; Li S; Zhang Y
Prostaglandins Other Lipid Mediat; 2013 Jan; 100-101():1-14. PubMed ID: 23219970
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways.
Gomez O; Sanchez-Rodriguez A; Le M; Sanchez-Caro C; Molina-Holgado F; Molina-Holgado E
Br J Pharmacol; 2011 Aug; 163(7):1520-32. PubMed ID: 21480865
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids.
Börner C; Höllt V; Sebald W; Kraus J
J Leukoc Biol; 2007 Jan; 81(1):336-43. PubMed ID: 17041005
[TBL] [Abstract][Full Text] [Related]
9. The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt.
Gómez del Pulgar T; Velasco G; Guzmán M
Biochem J; 2000 Apr; 347(Pt 2):369-73. PubMed ID: 10749665
[TBL] [Abstract][Full Text] [Related]
10. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
Mulè F; Amato A; Baldassano S; Serio R
Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
Tamir A; Granot Y; Isakov N
J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
[TBL] [Abstract][Full Text] [Related]
12. The kinase Itk and the adaptor TSAd change the specificity of the kinase Lck in T cells by promoting the phosphorylation of Tyr192.
Granum S; Sundvold-Gjerstad V; Gopalakrishnan RP; Berge T; Koll L; Abrahamsen G; Sørlie M; Spurkland A
Sci Signal; 2014 Dec; 7(355):ra118. PubMed ID: 25492967
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells.
Echigo R; Sugimoto N; Yachie A; Ohno-Shosaku T
Oncol Rep; 2012 Oct; 28(4):1176-80. PubMed ID: 22842590
[TBL] [Abstract][Full Text] [Related]
14. Characterization of anandamide-stimulated cannabinoid receptor signaling in human ULTR myometrial smooth muscle cells.
Brighton PJ; McDonald J; Taylor AH; Challiss RA; Lambert DG; Konje JC; Willets JM
Mol Endocrinol; 2009 Sep; 23(9):1415-27. PubMed ID: 19477951
[TBL] [Abstract][Full Text] [Related]
15. A weak Lck tail bite is necessary for Lck function in T cell antigen receptor signaling.
Nika K; Tautz L; Arimura Y; Vang T; Williams S; Mustelin T
J Biol Chem; 2007 Dec; 282(49):36000-9. PubMed ID: 17897955
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases.
Livolsi A; Busuttil V; Imbert V; Abraham RT; Peyron JF
Eur J Biochem; 2001 Mar; 268(5):1508-15. PubMed ID: 11231305
[TBL] [Abstract][Full Text] [Related]
17. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
McCollum L; Howlett AC; Mukhopadhyay S
J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
[TBL] [Abstract][Full Text] [Related]
18. Short-interfering RNA-mediated Lck knockdown results in augmented downstream T cell responses.
Methi T; Ngai J; Mahic M; Amarzguioui M; Vang T; Tasken K
J Immunol; 2005 Dec; 175(11):7398-406. PubMed ID: 16301647
[TBL] [Abstract][Full Text] [Related]
19. Lck Inhibits Heat Shock Protein 65-Mediated Reverse Cholesterol Transport in T Cells.
Luo T; Hu J; Xi D; Xiong H; He W; Liu J; Li M; Lu H; Zhao J; Lai W; Guo Z
J Immunol; 2016 Nov; 197(10):3861-3870. PubMed ID: 27742830
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of C-terminal Src kinase by siRNA-mediated RNA interference augments T cell receptor signaling in mature T cells.
Vang T; Abrahamsen H; Myklebust S; Enserink J; Prydz H; Mustelin T; Amarzguioui M; Tasken K
Eur J Immunol; 2004 Aug; 34(8):2191-9. PubMed ID: 15259016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
